What Are the Risk Factors for AMD?
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in adults over the age of 55. Although it is common, AMD is not inevitable—many of its strongest risk factors are identifiable, measurable, and modifiable. Understanding your personal risk profile is one of the most important steps you can take to protect your long‑term vision.
At Peter Ivins Eye Care in Bearsden, AMD risk assessment and prevention are core strengths. With cutting‑edge diagnostic technology, Scotland’s first Valeda photobiomodulation (PBM) clinic, and the deep clinical expertise of practice owner and international key opinion leader Craig McArthur, the practice offers one of the UK’s most advanced macular care pathways.
This article explains the major risk factors for AMD, why they matter, how we evaluate them, and how The Valeda Clinic combines early detection with innovative treatment to support retinal health.
What Is AMD?
AMD is a progressive condition affecting the macula—the central part of the retina responsible for detailed vision. It occurs in two main forms:
- Dry (atrophic) AMD – the most common form, associated with drusen deposits, inflammation, and eventual thinning of the retina.
- Wet (neovascular) AMD – a less common but more aggressive form in which abnormal blood vessels leak beneath the retina.
Risk factor identification is essential for slowing AMD progression and reducing the risk of developing advanced disease.
The Major Risk Factors for AMD
Below are the risk factors most strongly associated with the development and progression of AMD.
1. Age
Age is the single greatest risk factor. AMD becomes more common after age 55, and prevalence increases significantly after age 70.
While ageing is unavoidable, early detection and proactive management—especially through advanced imaging and lifestyle modification—can dramatically influence outcomes.
2. Family History & Genetics
A strong family history significantly increases your risk. AMD is known to have a genetic component, with certain gene variants (such as CFH and ARMS2) associated with higher susceptibility.
Patients with a first‑degree relative affected by AMD should undergo routine macular screening, OCT, fundus autofluorescence imaging, OCT-A and early preventative counselling.
3. Smoking (One of the Most Powerful Modifiable Risks)
Smoking doubles to triples the risk of AMD and accelerates disease progression.
Smoking damages the retina by:
- Increasing oxidative stress
- Reducing macular pigment levels
- Impairing blood supply to the retina
- Increasing inflammation
Stopping smoking is the single most effective lifestyle change to reduce AMD risk.
4. Low Macular Pigment Levels
Macular pigment—made up of lutein, zeaxanthin, and meso‑zeaxanthin—acts as natural antioxidant protection for the retina.
Low levels are associated with:
- Greater oxidative stress
- Higher AMD progression risk
- Lower contrast sensitivity
5. Diet & Nutrition
A diet low in antioxidants, leafy greens, omega‑3 fatty acids, and colourful fruits/vegetables raises AMD risk.
Evidence shows that a Mediterranean-style diet rich in:
- Green leafy vegetables
- Oily fish
- Yellow/orange fruit & vegetables
- Nuts and seeds
…is associated with significantly lower AMD risk.
AREDS2 supplements may be recommended for patients with moderate AMD or high-risk features.
6. Cardiovascular Health
Poor cardiovascular health is linked to increased AMD progression.
Risk elevates with:
- Hypertension
- High cholesterol
- Diabetes
- Atherosclerosis
These conditions affect the choroidal blood supply, which is essential for nourishing the retina.
7. High UV and Blue Light Exposure
Lifelong exposure to ultraviolet light and high-energy visible blue light may increase oxidative stress within the retina.
Protective strategies include:
- Wearing high‑quality UV‑blocking sunglasses
- Using blue‑light-filtering coatings in specific cases
- Personalised advice based on your macular health profile
8. Low Macular Blood Flow / Vascular Changes
OCT‑Angiography (OCT‑A) allows us to detect early changes in retinal and choroidal circulation.
Poor perfusion is associated with:
- Faster AMD progression
- Increased risk of geographic atrophy
- Greater likelihood of conversion to wet AMD
This advanced, non‑invasive imaging is part of every macular evaluation at Peter Ivins Eye Care.
9. High Drusen Load & Pigment Changes
The number, size, and type of drusen are important predictors of AMD progression.
Using the ZEISS CIRRUS 6000 OCT, fundus autofluorescence, and ZEISS CLARUS 500 true‑colour imaging, we quantify:
- Drusen size and volume
- Retinal pigment epithelium stress
- Early atrophy formation
These markers help determine whether early intervention—such as Valeda PBM—may be beneficial.
How Peter Ivins Eye Care Assesses AMD Risk
Peter Ivins Eye Care offers one of the most advanced AMD screening pathways in the UK.
Your assessment may include:
- ZEISS CIRRUS 6000 OCT (structural analysis)
- OCT‑A (blood‑flow imaging)
- ZEISS CLARUS 500 ultra‑widefield true‑colour imaging
- Fundus autofluorescence (metabolic mapping)
- Macular pigment density measurements
- AI‑enhanced progression analysis using ZEISS Retina Workplace and Altris AI
This multimodal approach reveals even the smallest early changes that traditional tests may miss.
Valeda PBM Therapy: Supporting Macular Health in At‑Risk Patients
The Valeda Light Delivery System offers a non‑invasive method of supporting retinal health using photobiomodulation.
Valeda PBM uses:
- 590 nm yellow light to reduce inflammation
- 660 nm red light to boost mitochondrial energy
- 850 nm near‑infrared light to promote tissue repair
PBM may help:
- Improve contrast sensitivity
- Enhance visual performance
- Support stressed RPE cells
- Improve mitochondrial function
- Slow functional decline in dry AMD
For patients with significant risk factors, or early macular changes, PBM may support overall retinal health and function.
Who Should Consider an AMD Risk Assessment?
You should book a macular evaluation if you:
- Are over age 55
- Have a family history of macular disease
- Are a smoker or ex‑smoker
- Have cardiovascular disease or high cholesterol
- Have difficulty with reading or contrast
- Notice wavy lines or missing areas on an Amsler grid
- Have been told you have drusen or pigment changes
- Want to take proactive steps for long‑term eye health
Valeda treatment – Book Now
…we can help you understand your baseline, your risk, and your options.
📞 Call us: 0141 943 3300
📍 Visit our clinic in Bearsden, Glasgow
📅 Book a Valeda Assessment online
Learn more at www.valedascotland.co.uk
For more information about Valeda treatment visit: